Kallikrein-Related Peptidase 13 (KLK13) (N-Term) Peptide
-
- Target See all Kallikrein 13 (KLK13) products
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Western Blotting (WB), Blocking Peptide (BP)
- Sequence
- GKHALGRVEA GEQVREVVHS IPHPEYRRSP THLNHDHDIM LLELQSPVQL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KLK13 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
- Synonyms
- KLK-L4 Peptide, KLKL4 Peptide, Egfbp-2 Peptide, mGk-13 Peptide, kallikrein related peptidase 13 Peptide, kallikrein related-peptidase 13 Peptide, KLK13 Peptide, Klk13 Peptide
- Background
-
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.
Alias Symbols: KLK13, KLKL4,
Protein Size: 277 - Gene ID
- 26085
- NCBI Accession
- NP_056411
- UniProt
- Q9UKR3
-